nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—ACHE—Biogenic Amine Synthesis—HDC—Gilles de la Tourette syndrome	0.0588	0.168	CbGpPWpGaD
Mefloquine—HBA1—nervous system—Gilles de la Tourette syndrome	0.0564	0.0866	CbGeAlD
Mefloquine—HBA1—central nervous system—Gilles de la Tourette syndrome	0.0543	0.0834	CbGeAlD
Mefloquine—HBA2—nervous system—Gilles de la Tourette syndrome	0.0518	0.0796	CbGeAlD
Mefloquine—HBA2—central nervous system—Gilles de la Tourette syndrome	0.0498	0.0766	CbGeAlD
Mefloquine—HBA1—brain—Gilles de la Tourette syndrome	0.0431	0.0662	CbGeAlD
Mefloquine—HBA2—brain—Gilles de la Tourette syndrome	0.0396	0.0608	CbGeAlD
Mefloquine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0338	0.0969	CbGpPWpGaD
Mefloquine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0302	0.0864	CbGpPWpGaD
Mefloquine—ADORA1—midbrain—Gilles de la Tourette syndrome	0.0283	0.0435	CbGeAlD
Mefloquine—ACHE—midbrain—Gilles de la Tourette syndrome	0.0281	0.0432	CbGeAlD
Mefloquine—ADORA2A—nervous system—Gilles de la Tourette syndrome	0.0269	0.0414	CbGeAlD
Mefloquine—ADORA2A—central nervous system—Gilles de la Tourette syndrome	0.0259	0.0399	CbGeAlD
Mefloquine—ADORA1—nervous system—Gilles de la Tourette syndrome	0.0233	0.0358	CbGeAlD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0225	0.0644	CbGpPWpGaD
Mefloquine—ADORA1—central nervous system—Gilles de la Tourette syndrome	0.0224	0.0344	CbGeAlD
Mefloquine—ADORA2A—brain—Gilles de la Tourette syndrome	0.0206	0.0317	CbGeAlD
Mefloquine—ADORA1—brain—Gilles de la Tourette syndrome	0.0178	0.0273	CbGeAlD
Mefloquine—ACHE—brain—Gilles de la Tourette syndrome	0.0177	0.0272	CbGeAlD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0174	0.0497	CbGpPWpGaD
Mefloquine—CYP19A1—nervous system—Gilles de la Tourette syndrome	0.0158	0.0242	CbGeAlD
Mefloquine—CYP19A1—central nervous system—Gilles de la Tourette syndrome	0.0152	0.0233	CbGeAlD
Mefloquine—ADORA2A—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.014	0.04	CbGpPWpGaD
Mefloquine—BCHE—midbrain—Gilles de la Tourette syndrome	0.0138	0.0212	CbGeAlD
Mefloquine—CYP19A1—brain—Gilles de la Tourette syndrome	0.0121	0.0185	CbGeAlD
Mefloquine—BCHE—nervous system—Gilles de la Tourette syndrome	0.0114	0.0175	CbGeAlD
Mefloquine—ACHE—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.0112	0.032	CbGpPWpGaD
Mefloquine—BCHE—central nervous system—Gilles de la Tourette syndrome	0.0109	0.0168	CbGeAlD
Mefloquine—HBA2—Metabolism—HDC—Gilles de la Tourette syndrome	0.00938	0.0269	CbGpPWpGaD
Mefloquine—BCHE—brain—Gilles de la Tourette syndrome	0.00869	0.0133	CbGeAlD
Mefloquine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00765	0.0118	CbGeAlD
Mefloquine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00753	0.0116	CbGeAlD
Mefloquine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00737	0.0113	CbGeAlD
Mefloquine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00725	0.0111	CbGeAlD
Mefloquine—HBA1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00711	0.0204	CbGpPWpGaD
Mefloquine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.00659	0.0101	CbGeAlD
Mefloquine—ADORA2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00658	0.0188	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00639	0.0183	CbGpPWpGaD
Mefloquine—CYP2D6—brain—Gilles de la Tourette syndrome	0.00575	0.00884	CbGeAlD
Mefloquine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.00542	0.00832	CbGeAlD
Mefloquine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.00521	0.00801	CbGeAlD
Mefloquine—ADORA1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00452	0.0129	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00439	0.0126	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00417	0.0119	CbGpPWpGaD
Mefloquine—ABCB1—brain—Gilles de la Tourette syndrome	0.00414	0.00636	CbGeAlD
Mefloquine—ADORA1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00409	0.0117	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00399	0.0114	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00387	0.0111	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0037	0.0106	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00361	0.0103	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0036	0.0103	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00349	0.01	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00339	0.00971	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00335	0.00959	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00317	0.00909	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00316	0.00904	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00308	0.00882	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00287	0.00822	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00286	0.00819	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00278	0.00795	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00259	0.0074	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00258	0.00738	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00245	0.00701	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00242	0.00692	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00238	0.00681	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00235	0.00672	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00235	0.00672	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0023	0.00658	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00222	0.00634	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00219	0.00626	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00201	0.00575	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00197	0.00565	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00187	0.00534	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00181	0.00519	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00181	0.00519	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00176	0.00504	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00169	0.00483	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00155	0.00444	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00153	0.00438	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—HDC—Gilles de la Tourette syndrome	0.00143	0.00409	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00137	0.00391	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00133	0.0038	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00131	0.00376	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—HDC—Gilles de la Tourette syndrome	0.00127	0.00365	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00124	0.00355	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00123	0.00354	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.0012	0.00345	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00118	0.00338	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00112	0.00321	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00105	0.00302	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00102	0.00293	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000957	0.00274	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000953	0.00273	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000929	0.00266	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000866	0.00248	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000865	0.00248	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000785	0.00225	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000733	0.0021	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000711	0.00204	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000668	0.00191	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000662	0.0019	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000622	0.00178	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000606	0.00174	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000586	0.00168	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000566	0.00162	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000549	0.00157	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000511	0.00146	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000464	0.00133	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000462	0.00132	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000383	0.0011	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000358	0.00103	CbGpPWpGaD
